GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles to Deliver Genetic Medicines for Autoimmune Disease by Jessica | Jan 23, 2024 Read more »
Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program by Jessica | Nov 14, 2023 Read more »
Artiva Biotherapeutics Receives Immunology Innovation of the Year in the 2023 BioTech Breakthrough Awards Program by Jessica | Nov 8, 2023 Read more »
